3D Medicines Inc. (01244)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Chen Yawen | 12-Jul-22 | NED | |||
| Gong Zhaolong | 09-Oct-19 | Ch, CEO, Fdr | |||
| Li Ching Yi | 25-Jun-21 | CoSec | |||
| 30-Jun-26 | AuRep | Ms. Li has tendered her resignation following the confirmation that Ms. Xia is qualified to act as the company secretary. | |||
| Li Jin | 15-Dec-22 | INED | |||
| Lin Vincent Tat Pang | 15-Dec-22 | INED | |||
| Liu Xinguang | 15-Dec-22 | INED | |||
| Wu Gang | 24-Jun-21 | 08-Jul-22 | NED | ||
| Xia Fang | 30-Jun-26 | AuRep | |||
| 25-Jun-21 | CoSec | ||||
| Zhang Jing | 28-Aug-20 | 12-Jan-26 | CFO | Ms. Zhang has tendered her resignation. | |
| Zhou Feng | 30-Jun-25 | MbAC | |||
| 09-Oct-19 | NED | ||||
| Zhu Pai | 23-Jun-21 | 30-Jun-25 | NED | Retirement upon the expiry of his term of office to devote more time to pursue other work engagements. | |
| 30-Jun-25 | MbAC | Retirement |